FR2380782A1 - Fraction 5 de thymosine stabilisee utile comme medicament et procede pour la preparer - Google Patents
Fraction 5 de thymosine stabilisee utile comme medicament et procede pour la preparerInfo
- Publication number
- FR2380782A1 FR2380782A1 FR7804718A FR7804718A FR2380782A1 FR 2380782 A1 FR2380782 A1 FR 2380782A1 FR 7804718 A FR7804718 A FR 7804718A FR 7804718 A FR7804718 A FR 7804718A FR 2380782 A1 FR2380782 A1 FR 2380782A1
- Authority
- FR
- France
- Prior art keywords
- thymosin
- fraction
- useful
- stabilized
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/770,480 US4082737A (en) | 1977-02-22 | 1977-02-22 | Stabilized thymosin composition and method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2380782A1 true FR2380782A1 (fr) | 1978-09-15 |
| FR2380782B1 FR2380782B1 (US06582424-20030624-M00016.png) | 1980-01-18 |
Family
ID=25088687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7804718A Granted FR2380782A1 (fr) | 1977-02-22 | 1978-02-20 | Fraction 5 de thymosine stabilisee utile comme medicament et procede pour la preparer |
Country Status (20)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2732587A1 (de) * | 1976-09-22 | 1978-03-23 | Bach Jean Francois | Polypeptid mit thymischer wirksamkeit |
| US4148788A (en) * | 1978-01-23 | 1979-04-10 | Hoffmann-La Roche Inc. | Synthesis of thymosin α1 |
| US4239498A (en) * | 1978-11-27 | 1980-12-16 | Rule Allyn H | Method of preparing thymic factors and composition |
| US4264571A (en) * | 1979-01-22 | 1981-04-28 | George Washington University | Radioimmunoassay of thymosin α1 |
| WO1982000407A1 (en) * | 1980-08-08 | 1982-02-18 | Sykes A | Improved racking |
| US4389343A (en) * | 1981-12-24 | 1983-06-21 | Hoffmann-La Roche Inc. | Immunopotentiating peptides from thymus |
| US4388234A (en) * | 1981-12-28 | 1983-06-14 | Hoffmann-La Roche Inc. | Peptide isolation |
| US4614731A (en) * | 1983-09-15 | 1986-09-30 | Hoffmann-La Roche Inc. | Peptide having immunopotentiating activity similar to thymosin alpha1 |
| US4659694A (en) * | 1983-10-27 | 1987-04-21 | Hoffmann-La Roche Inc. | Prothymosin alpha |
| US4814434A (en) * | 1984-02-03 | 1989-03-21 | Ventres Laboratories, Inc. | Inducer of T-suppressor cells |
| DE3633651A1 (de) * | 1986-10-03 | 1988-04-14 | Alfred Dr Dick | Verwendung von fraktionen aus thymus- und milzextrakten zur behandlung der psoriasis |
| US5273963A (en) * | 1991-03-29 | 1993-12-28 | The George Washington University | Compositions and methods for treating small cell and nonsmall cell lung cancers |
| JP4404866B2 (ja) | 2006-03-03 | 2010-01-27 | ゼライス株式会社 | エンドトキシン含有量を低減したゼラチンの製造方法および低エンドトキシンゼラチン |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4002602A (en) * | 1974-03-11 | 1977-01-11 | Gideon Goldstein | Ubiquitous immunopoietic polypeptide (UBIP) and methods |
| US4010148A (en) * | 1975-05-12 | 1977-03-01 | Board Of Regents Of The University Of Texas System | Purified thymosin and process |
| US4002740A (en) * | 1975-08-21 | 1977-01-11 | Gideon Goldstein | Tridecapeptide compositions and methods |
-
1977
- 1977-02-22 US US05/770,480 patent/US4082737A/en not_active Expired - Lifetime
-
1978
- 1978-01-18 CH CH51178A patent/CH632164A5/de not_active IP Right Cessation
- 1978-01-30 IT IT19791/78A patent/IT1092337B/it active
- 1978-02-06 CA CA296,326A patent/CA1099633A/en not_active Expired
- 1978-02-07 NL NLAANVRAGE7801422,A patent/NL189281C/xx not_active IP Right Cessation
- 1978-02-15 NZ NZ186489A patent/NZ186489A/xx unknown
- 1978-02-15 ZA ZA00780890A patent/ZA78890B/xx unknown
- 1978-02-16 IL IL54063A patent/IL54063A0/xx not_active IP Right Cessation
- 1978-02-16 AU AU33343/78A patent/AU516946B2/en not_active Expired
- 1978-02-16 IE IE335/78A patent/IE46409B1/en not_active IP Right Cessation
- 1978-02-20 DE DE2807202A patent/DE2807202C2/de not_active Expired
- 1978-02-20 LU LU79090A patent/LU79090A1/xx unknown
- 1978-02-20 JP JP1774678A patent/JPS53104719A/ja active Granted
- 1978-02-20 FR FR7804718A patent/FR2380782A1/fr active Granted
- 1978-02-21 GB GB6845/78A patent/GB1546027A/en not_active Expired
- 1978-02-21 DK DK78378A patent/DK78378A/da unknown
- 1978-02-21 PH PH20803A patent/PH13858A/en unknown
- 1978-02-21 BE BE185321A patent/BE864139A/xx not_active IP Right Cessation
- 1978-02-21 AT AT0124578A patent/AT363177B/de not_active IP Right Cessation
- 1978-02-21 SE SE7802014A patent/SE444647B/sv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU516946B2 (en) | 1981-07-02 |
| IL54063A0 (en) | 1978-04-30 |
| SE7802014L (sv) | 1978-08-23 |
| AT363177B (de) | 1981-07-10 |
| SE444647B (sv) | 1986-04-28 |
| IE46409B1 (en) | 1983-06-01 |
| NL7801422A (nl) | 1978-08-24 |
| JPS618806B2 (US06582424-20030624-M00016.png) | 1986-03-18 |
| ATA124578A (de) | 1980-12-15 |
| DK78378A (da) | 1978-08-23 |
| PH13858A (en) | 1980-10-22 |
| ZA78890B (en) | 1979-01-31 |
| IT1092337B (it) | 1985-07-06 |
| GB1546027A (en) | 1979-05-16 |
| IT7819791A0 (it) | 1978-01-30 |
| NL189281B (nl) | 1992-10-01 |
| NZ186489A (en) | 1981-01-23 |
| AU3334378A (en) | 1979-08-23 |
| DE2807202A1 (de) | 1978-08-24 |
| FR2380782B1 (US06582424-20030624-M00016.png) | 1980-01-18 |
| DE2807202C2 (de) | 1987-04-02 |
| CH632164A5 (de) | 1982-09-30 |
| JPS53104719A (en) | 1978-09-12 |
| CA1099633A (en) | 1981-04-21 |
| NL189281C (nl) | 1993-03-01 |
| IE780335L (en) | 1978-08-22 |
| LU79090A1 (fr) | 1979-05-25 |
| BE864139A (fr) | 1978-08-21 |
| US4082737A (en) | 1978-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2380782A1 (fr) | Fraction 5 de thymosine stabilisee utile comme medicament et procede pour la preparer | |
| ATE271863T1 (de) | Schilddrüsenhormone enthaltende stabilisierte arzneimittel und verfahren | |
| ES2113346T3 (es) | Metodo para potenciar el transporte de moleculas exogenas a traves de la membrana. | |
| KR950016783A (ko) | 조절 방출용 약학 조성물 | |
| SE8300623L (sv) | Farmaceutisk komposition innehallande stabil mikrokristallin cis-platina(ii)-diammindiklorid (cisplatin) | |
| NO870560L (no) | Nytt farmasoeytisk preparat. | |
| ATE53296T1 (de) | Spritzfertige, waessrige, alkalische injektionsloesung von torasemid und verfahren zu ihrer herstellung. | |
| EA199600024A2 (ru) | Жидкая стабильная фармацевтическая композиция, содержащая уратоксидазу и лиофилизат для ее получения | |
| EP0173664A3 (en) | Biologically active benzimidazole compounds and process for their preparation | |
| HU907653D0 (en) | Process for the preparation of a medical product with cyclosporine content for oral use | |
| KR830002510A (ko) | 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물 | |
| EA000211B1 (ru) | Фармацевтические композиции для парентерального применения, содержащие индолкарбоновые кислоты | |
| TR199800716T2 (xx) | Trombosit k�melenme inhibit�rleri ihtiva eden farmas�tik terkipler. | |
| US4822782A (en) | Method for treating AIDS using streptovaricin C compounds | |
| KR910015297A (ko) | 오메프라졸 경구용 약제와 그 제조방법 | |
| JPS6045532A (ja) | 血糖降下剤 | |
| SE8106498L (sv) | Kvaternera salter av n,n3-di(beta-brompropionyl)-n1,n2-dispirotripiperazinium, forfarande for framstellning av desamma och lekemedelspreparat innehallande desamma | |
| KR950000149A (ko) | 오메프라졸 주사용 제제 | |
| KR880003623A (ko) | 시알로실글리세로리피드로 된 신경장해질환 치료제 | |
| KR820000291B1 (ko) | 불용성 약제의 가용화 방법 | |
| Spencer et al. | The Influence of Cyclosporin on Cytomegalovirus-Related Kidney Graft Survival | |
| JPS6045527A (ja) | 血圧降下剤 | |
| KR960041363A (ko) | 우레이트 옥시디아제를 함유하는 안정한 액체 조성물 및 그의 제조를 위한 동결건조조성물 | |
| KR890001528A (ko) | 성인 t-세포 백혈병/임파종의 억제를 위한 아바론, 아바롤 및 그 유도체의 용도 | |
| KR900000081A (ko) | 트리암테렌의 약학적 액제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TP | Transmission of property | ||
| ST | Notification of lapse |